1-4 of 4
Yukari Masuta
Close
Sort by
Journal Articles

Combination Therapy of Humanized Chimeric-Anti-Human VLA4 Monoclonal Antibodies and Anti-Cancer Drugs for AML.

Takuya Matsunaga, MD, Kazunori Kato, PhD, Maki Tanaka, MD, Yukari Masuta, PhD, Kageaki Kuribayashi, MD, Naofumi Takemoto, MD, Ikuta Tanaka, MD, Akihito Fujimi, MD, Takehide Akiyama, MD, Hirofumi Hamada, MD, Yoshiro Niitsu, MD
Journal: Blood
Blood (2004) 104 (11): 4518.
https://doi.org/10.1182/blood.V104.11.4518.4518
Published: 2004
Journal Articles

A Novel Non-Cleavable Cell Surface Mutant of CD40-Ligand Induces Anti-Leukemic Immune Response and Prevent Systemic Inflammatory Reaction.

Kazunori Kato, PhD, Yukari Masuta, Kei Tomihara, DDS, Katsunori Sasaki, PhD, Hirofumi Hamada, MD
Journal: Blood
Blood (2004) 104 (11): 3174.
https://doi.org/10.1182/blood.V104.11.3174.3174
Published: 2004
Journal Articles

Selective and Efficient Gene Delivery of CD40-Ligand by a Fiber-Modified Adenovirus Vector with Specific Antibody to Human Leukemia and Myeloma.

Kazunori Kato, PhD, Sachie Hirai, Yukari Masuta, Aiko Kuroishi, Kiminori Nakamura, PhD, DDS, Hirofumi Hamada, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 5263.
https://doi.org/10.1182/blood.V104.11.5263.5263
Published: 2004
Journal Articles

Gene Transfer of CD40-Ligand to Human Dendritic Cells Induces Growth Arrest and Apoptosis of Tumor Cells Mediated by Up-Regulated TRAIL and its Receptors.

Kei Tomihara, DDS, Kazunori Kato, PhD, Yukari Masuta, Makoto Noguchi, DDS, PhD, Hiroyoshi Hiratsuka, DDS, PhD, Hirofumi Hamada, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 3454.
https://doi.org/10.1182/blood.V104.11.3454.3454
Published: 2004